SINGAPORE – Media OutReach Newswire – 12 March 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis® (Tadalafil), a leading men’s health product...
SINGAPORE – Media OutReach Newswire – 9 February 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex® consumer healthcare brands...
SINGAPORE – Media OutReach Newswire – 16 December 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has expanded its partnership with H. Lundbeck A/S (“Lundbeck”), a biopharmaceutical company focusing exclusively on brain health....
New facility is set to be South Korea’s most advanced automated hub for clinical logistics and sourcing, reinforcing the nation’s position as a leader in clinical research innovation GYEONGGI-DO, SOUTH KOREA – Media OutReach Newswire – 1 December 2025 –...
Mounjaro® (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the...
SINGAPORE – Media OutReach Newswire – 7 January 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of Propan, a market leading brand in the multivitamin-appetite stimulant segment, from ADP...
